Cancer Policy: Pharmaceutical Safety
Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chap...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Cancer Treatment and Research,
171 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Pharmacovigilance programs: Do they improve Cancer Drug Safety?
- Impact of Cost on the Safety of Cancer pharmaceuticals
- Assessing pharmaceutical safety in Geriatric Oncology
- Cancer co-Morbidity: Implications for Drug Safety
- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?
- Pharmacovigilance of alternative medications in the Cancer Setting
- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology
- Biosimilars: Are they really safe?
- Natural Language processing: improving the identification and communication of Cancer Drug Safety
- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety
- Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
- Cancer Drug Toxicity: Moving from patient to Survivor.